Christian Antoine Lucien Ribeyrolle's most recent trade in Rayonier Advanced Materials Inc was a trade of 10,458 Common Stock done . Disclosure was reported to the exchange on March 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rayonier Advanced Material... | Christian Antoine Lucien Ribeyrolle | SVP, Biomaterials | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 10,458 | 38,424 (0%) | 0% | 0 | Common Stock | |
| Rayonier Advanced Material... | Christian Antoine Lucien Ribeyrolle | SVP, Biomaterials | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 13,021 | 0 | - | - | Restricted Stock Units | |
| Rayonier Advanced Material... | Christian Antoine Lucien Ribeyrolle | SVP, Biomaterials | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 13,021 | 27,966 (0%) | 0% | 0 | Common Stock | |
| Rayonier Advanced Material... | Christian Antoine Lucien Ribeyrolle | SVP, Biomaterials | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 9,741 | 9,741 | - | - | Restricted Stock Units | |
| Rayonier Advanced Material... | Christian Antoine Lucien Ribeyrolle | SVP, Biomaterials | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 8,572 | 8,572 | - | - | Restricted Stock Units | |
| Rayonier Advanced Material... | Christian Antoine Lucien Ribeyrolle | SVP, Biomaterials | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 2,881 | 14,945 (0%) | 0% | 0 | Common Stock | |
| Rayonier Advanced Material... | Christian Antoine Lucien Ribeyrolle | SVP, Biomaterials | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 2,881 | 0 | - | - | Restricted Stock Units | |
| Rayonier Advanced Material... | Christian Antoine Lucien Ribeyrolle | Vice President, Biomaterials | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 8,940 | 8,940 | - | - | Restricted Stock Units | |
| Rayonier Advanced Material... | Christian Antoine Lucien Ribeyrolle | Vice President, Biomaterials | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 4,805 | 8,730 (0%) | 0% | 0 | Common Stock | |
| Rayonier Advanced Material... | Christian Antoine Lucien Ribeyrolle | Vice President, Biomaterials | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 3,334 | 0 | - | - | Restricted Stock Units | |
| Rayonier Advanced Material... | Christian Antoine Lucien Ribeyrolle | Vice President, Biomaterials | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 3,334 | 12,064 (0%) | 0% | 0 | Common Stock | |
| Rayonier Advanced Material... | Christian Antoine Lucien Ribeyrolle | Vice President, Biomaterials | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 13,021 | 13,021 | - | - | Restricted Stock Units |